Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Prevest Denpro
Join Channel
Consolidated Standalone

Prevest Denpro

₹392.8 3.1 | 0.8%

Market Cap ₹471 Cr.

Stock P/E 28.6

P/B 5.6

Current Price ₹392.8

Book Value ₹ 69.9

Face Value 10

52W High ₹607.5

Dividend Yield 0.25%

52W Low ₹ 332

Edit Ratio

Prevest Denpro Research see more...

Overview Inc. Year: 1999Industry: Medical Equipment/Supplies/Accessories

Prevest Denpro Ltd develops, manufactures, and markets dental substances for diagnosing, treating, and preventing dental situations, as well as for boosting the aesthetics of the human smile in Europe, Asia, South America, the Middle East, and Africa. Its product portfolio consists of adhesives, bonding marketers, and etchants; composites; cements and liners; endodontics; orthodontics; finishing and polishing merchandise; auxiliaries; impression substances; haemostatic substances; tooth whitening merchandise; oral care merchandise; retraction materials; and transient and lab substances. The enterprise was incorporated in 1999 and is primarily based in Samba, India.

Read More..

Prevest Denpro Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Prevest Denpro Quarterly Results

#(Fig in Cr.) Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023
Net Sales 11 9 12 11 12 14
Other Income 0 1 1 1 1 0
Total Income 12 10 13 12 13 14
Total Expenditure 7 6 8 7 7 8
Operating Profit 5 4 5 5 5 6
Interest 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0
Profit Before Tax 5 4 5 5 5 6
Provision for Tax 1 1 1 2 2 1
Profit After Tax 4 2 4 3 4 5
Adjustments 0 0 0 0 -0 0
Profit After Adjustments 4 2 4 3 4 5
Adjusted Earnings Per Share 3.1 2.1 3.1 2.8 3 4.3

Prevest Denpro Profit & Loss

#(Fig in Cr.) Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 17 19 23 28 38 50 49
Other Income 1 0 2 1 2 2 3
Total Income 18 20 25 30 40 52 52
Total Expenditure 14 15 18 19 23 30 30
Operating Profit 4 4 7 10 17 22 21
Interest 0 0 0 0 0 0 0
Depreciation 0 0 0 0 1 1 0
Exceptional Income / Expenses 0 0 0 0 0 0 0
Profit Before Tax 3 4 6 9 16 21 21
Provision for Tax 1 1 1 2 4 5 6
Profit After Tax 2 3 5 7 12 16 16
Adjustments 0 0 0 0 0 0 0
Profit After Adjustments 2 3 5 7 12 16 16
Adjusted Earnings Per Share 2.5 3.4 5.7 8.2 9.6 13.1 13.2

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 32% 30% 24% 0%
Operating Profit CAGR 29% 46% 41% 0%
PAT CAGR 33% 47% 52% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -8% NA% NA% NA%
ROE Average 24% 30% 33% 32%
ROCE Average 32% 40% 41% 40%

Prevest Denpro Balance Sheet

#(Fig in Cr.) Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 7 10 15 22 57 73
Minority's Interest 0 0 0 0 0 0
Borrowings 1 1 2 1 1 0
Other Non-Current Liabilities 0 0 0 0 0 0
Total Current Liabilities 3 3 4 7 5 5
Total Liabilities 11 15 21 31 64 79
Fixed Assets 4 5 5 5 7 7
Other Non-Current Assets 0 0 0 2 5 17
Total Current Assets 7 10 16 24 53 54
Total Assets 11 15 21 31 64 79

Prevest Denpro Cash Flow

#(Fig in Cr.) Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 3 4 6 10 16 42
Cash Flow from Operating Activities 2 3 5 9 7 11
Cash Flow from Investing Activities -1 -1 -1 -2 -4 -12
Cash Flow from Financing Activities -0 0 0 -1 23 -2
Net Cash Inflow / Outflow 1 2 4 6 26 -3
Closing Cash & Cash Equivalent 4 6 10 16 42 39

Prevest Denpro Ratios

# Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 2.46 3.39 5.67 8.16 9.64 13.09
CEPS(Rs) 2.93 3.85 6.17 8.69 10.07 13.65
DPS(Rs) 0 0 0 0 0 1
Book NAV/Share(Rs) 8.27 11.66 17.32 25.46 47.56 60.65
Core EBITDA Margin(%) 16.71 19.43 22.31 31.1 38.67 39.03
EBIT Margin(%) 17.77 19.88 28.12 33.05 41.46 41.7
Pre Tax Margin(%) 16.52 18.84 26.98 32.18 40.77 41.29
PAT Margin (%) 12.26 15.02 21.53 24.84 29.39 30.95
Cash Profit Margin (%) 14.6 17.04 23.42 26.47 30.72 32.28
ROA(%) 18.88 22.3 27.5 27.85 24.4 22.01
ROE(%) 29.72 34.02 39.13 38.13 29.07 24.19
ROCE(%) 37.15 39.27 45.63 46.96 39.64 32.25
Receivable days 31.82 36.55 36.13 37.14 28.13 23.82
Inventory Days 10.03 9.03 12.78 15.12 21.03 28.96
Payable days 71.56 64.28 68.67 122.26 104.63 44.34
PER(x) 0 0 0 0 37.45 21.25
Price/Book(x) 0 0 0 0 7.59 4.59
Dividend Yield(%) 0 0 0 0 0 0.36
EV/Net Sales(x) -0.16 -0.23 -0.37 -0.52 10.29 5.91
EV/Core EBITDA(x) -0.77 -1 -1.2 -1.47 23.29 13.5
Net Sales Growth(%) 0 13.53 18.12 25.06 33.84 30.81
EBIT Growth(%) 0 25.97 65.02 46.61 70.21 29.68
PAT Growth(%) 0 37.92 67.3 43.88 60.53 35.8
EPS Growth(%) 0 37.92 67.3 43.88 18.16 35.8
Debt/Equity(x) 0.16 0.14 0.11 0.06 0.02 0
Current Ratio(x) 2.61 3 4.08 3.61 9.76 9.98
Quick Ratio(x) 2.43 2.85 3.78 3.41 9.16 9.1
Interest Cover(x) 14.3 19.1 24.8 37.69 60.34 100.94
Total Debt/Mcap(x) 0 0 0 0 0 0

Prevest Denpro Shareholding Pattern

# Sep 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 73.6 73.6 73.6 73.6 73.6 73.6 73.6 73.6 73.6 73.6
FII 4.63 0.76 0.66 0.47 0.21 0.3 0.26 0.31 0.31 0.52
DII 4.37 1.24 1.19 1.16 0.95 0.95 0.61 0.71 0.68 0.68
Public 17.4 24.4 24.55 24.77 25.23 25.14 25.53 25.37 25.41 25.2
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company has delivered good profit growth of 51% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 30%
  • Debtor days have improved from 104.63 to 44.34days.
  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Stock is trading at 5.6 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Prevest Denpro News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!